Overview

• The trial, which began on April 3, 2025, at the tribunal judiciaire de Vienne, is the first worldwide to address congenital malformations allegedly linked to glyphosate exposure.
• Théo Grataloup, now 17, was born with severe malformations of the trachea and esophagus, requiring over 50 surgeries to date.
• His mother, Sabine Grataloup, unknowingly used a glyphosate-based herbicide during early pregnancy in 2006, a critical period for fetal development.
• The family is seeking judicial recognition of a causal link between glyphosate and Théo's condition, as well as damages from Bayer-Monsanto.
• Bayer has not commented on the case, which could set a global precedent for corporate accountability in glyphosate-related health risks.